3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neoplasms
8
Colorectal Neoplasms
7
Prostatic Neoplasms
6
Stomach Neoplasms
5
Lung Neoplasms
5
Breast Neoplasms
5
Endometrial Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Sarcoma
3
Pancreatic Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Oropharyngeal Neoplasms
2
Obesity
2
Meningioma
2
Melanoma
2
Lymphoma, Large B-Cell, Diffuse
2
Esophageal Neoplasms
2
Disease
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Surgical Wound Dehiscence
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Small Cell Lung Carcinoma
1
Skull Base Neoplasms
1
Skin Neoplasms
1
Salivary Gland Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
20
Temozolomide
16
Radiotherapy
10
Specimen Handling
7
Blood Specimen Collection
7
Radiation
6
Bevacizumab
5
Nivolumab
4
Cyclophosphamide
4
Biopsy
4
vorasidenib
3
trametinib
3
pembrolizumab
3
olaparib
3
fludarabine
3
dabrafenib
3
Watchful Waiting
3
Surgical Procedures, Operative
3
Magnetic Resonance Imaging
3
Drug Therapy
3
olutasidenib
2
lutetium Lu 177 dotatate
2
fluorodopa F 18
2
fluciclovine F-18
2
entrectinib
2
contrast agent BR1
2
X-Rays
2
Restraint, Physical
2
Radiosurgery
2
Microdialysis
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Glioma
×
Observation
×
Clear all
NCT07025226
2026-01-26
Senolytics
Mayo Clinic
Phase EARLY_PHASE1
Recruiting
10 enrolled